Dr. Thomas Edward Lad, MD

Dr. Lad practices at John H. Stroger, Jr. Hospital of Cook County in Chicago, Illinois, part of Cook County Government.

Dr. Lad's NPI, 1972511632, was assigned on August 4, 2006. Dr. Lad graduated from Ohio State University College of Medicine in 1971. Dr. Lad holds Illinois license 036-045861.

Dr. Lad's primary practice is John H. Stroger, Jr. Hospital of Cook County, at 1901 W Harrison St, Chicago, IL 60612 in Cook County. The practice phone is (312) 864-6000.

Dr. Lad's primary practice is John H. Stroger, Jr. Hospital of Cook County in Chicago, Illinois, part of Cook County Government. The medical group on file is John H. Stroger, Jr. Hospital of Cook County.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lad practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Lad's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lad is licensed in Illinois.

CMS data shows 175 Medicare services from Dr. Lad across 2 procedure codes in 2024, all of them office visits, for 97 Medicare patients. Medicare paid $10,941 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Lad in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have cancer, and 75% have high blood pressure. 75% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lad's median patient age at 69, with 75% women.

In 2024, Dr. Lad wrote 819 Medicare Part D claims for 127 patients. 72% of them were for generic drugs. CMS names the drug for 561 of them, across 24 drugs with 11 or more claims each, at $3,523,743 in total drug cost. In 2023, CMS named 430 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Lad for performance year 2024, reported as part of a group.

Dmand AI links 25 papers to Dr. Lad, published from 2012 to 2024. 2023 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Cancer Survivors and Carcinoma, Non-Small-Cell Lung. Dr. Lad has published most often in Cancer. Dr. Lad's most frequent co-authors are Ankit Mangla, MD, David F. Cella, PhD and Carla I. Falkson, MD.

Dmand AI links Dr. Lad to 11 clinical trials, 6 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Non-Small-Cell Lung. National Cancer Institute (NCI) sponsors the most, 7. Open Payments lists research payments to Dr. Lad that name 1 trial.

CMS Open Payments shows 14 general payments to Dr. Lad from 12 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 86% of the total. Bristol-Myers Squibb Company paid the most, $52. It also lists 1 research payment totaling $260 in 2018, naming 1 clinical trial.

Dr. Lad graduated from Ohio State University College of Medicine in 1971.